Clinical Trial: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

Brief Summary: The purpose of this study is to determine the safety of the combination of CHOP plus daclizumab in patients with ATLL previously untreated with anthracycline based chemotherapy.

Detailed Summary:
Sponsor: King's College Hospital NHS Trust

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: King's College Hospital NHS Trust

Dates:
Date Received: August 16, 2011
Date Started:
Date Completion:
Last Updated: August 19, 2011
Last Verified: July 2011